Medical screening -- United States -- Cost effectivenessSee also what's at your library, or elsewhere.
Broader terms: |
Filed under: Medical screening -- United States -- Cost effectiveness
Items below (if any) are from related and broader terms.
Filed under: Medical screening -- United States- Effectiveness and Costs of Osteoporosis Screening and Hormone Replacement Therapy (1995), by United States Congress Office of Technology Assessment
- Medical Testing and Health Insurance (OTA-H-384; 1988), by United States Congress Office of Technology Assessment
- Medical Monitoring and Screening in the Workplace: Results of a Survey (Washington: GPO, 1991), by United States Congress Office of Technology Assessment
- Genetic Tests and Health Insurance: Results of a Survey (1992), by United States Congress Office of Technology Assessment
Filed under: Drug testing -- United States -- CongressesFiled under: Genetic screening -- United States- Genetic Counseling and Cystic Fibrosis Carrier Screening: Results of a Survey (1992), by United States Congress Office of Technology Assessment
Filed under: Genetic screening -- Moral and ethical aspects -- United States- Genetic Monitoring and Screening in the Workplace (1990), by United States Congress Office of Technology Assessment
Filed under: Medical screening -- Moral and ethical aspects -- United States
Filed under: Cost effectiveness
Filed under: Cost effectiveness -- Case studies
Filed under: Angiography -- Digital techniques -- Cost effectivenessFiled under: Cimetidine -- Cost effectivenessFiled under: Cocaine abuse -- United States -- Prevention -- Cost effectivenessFiled under: Continuous ambulatory peritoneal dialysis -- United States -- Cost effectivenessFiled under: Diagnosis -- Cost effectivenessFiled under: Drug abuse -- Study and teaching -- United States -- Cost effectivenessFiled under: Heart, Artificial -- Cost effectivenessFiled under: Influenza -- United States -- Prevention -- Cost effectivenessFiled under: Medical care -- Cost effectiveness- The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
Filed under: Medical instruments and apparatus -- Cost effectiveness- Cardiac Radionuclide Imaging and Cost Effectiveness (1982), by William B. Stason and Eric Fortess (PDF files at Princeton)
- Assessing Selected Respiratory Therapy Modalities: Trends and Relative Costs in the Washington, D.C., Area (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- The Costs and Effectiveness of Nurse Practitioners (1981), by Lauren LeRoy and Sharon Solkowitz (PDF files at Princeton)
- The Feasibility of Economic Evaluation of Diagnostic Procedures: The Case of CT Scanning (Washington: Office of Technology Assessment, 1981), by Judith L. Wagner (PDF files at Princeton)
- Periodontal Disease: Assessing the Effectiveness and Costs of the Keyes Technique (OTA background paper #2, case study #5, for "The Implications of Cost-Effectiveness Analysis of Medical Technology"; 1980), by Richard M. Scheffler and Sheldon Rovin (PDF files at Princeton)
- Allocating Costs and Benefits in Disease Prevention Programs: An Application to Cervical Cancer Screening (1981), by Bryan R. Luce (PDF files at Princeton)
- Benefit-And-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton)
Filed under: Medical technology -- Cost effectiveness- Cardiac Radionuclide Imaging and Cost Effectiveness (1982), by William B. Stason and Eric Fortess (PDF files at Princeton)
- Assessing Selected Respiratory Therapy Modalities: Trends and Relative Costs in the Washington, D.C., Area (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- The Costs and Effectiveness of Nurse Practitioners (1981), by Lauren LeRoy and Sharon Solkowitz (PDF files at Princeton)
- The Feasibility of Economic Evaluation of Diagnostic Procedures: The Case of CT Scanning (Washington: Office of Technology Assessment, 1981), by Judith L. Wagner (PDF files at Princeton)
- Periodontal Disease: Assessing the Effectiveness and Costs of the Keyes Technique (OTA background paper #2, case study #5, for "The Implications of Cost-Effectiveness Analysis of Medical Technology"; 1980), by Richard M. Scheffler and Sheldon Rovin (PDF files at Princeton)
- Allocating Costs and Benefits in Disease Prevention Programs: An Application to Cervical Cancer Screening (1981), by Bryan R. Luce (PDF files at Princeton)
- Benefit-And-Cost Analysis of Medical Interventions: The Case of Cimetidine and Peptic Ulcer Disease (1981), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
Filed under: Medical technology -- United States -- Cost effectiveness- The Implications of Cost-Effectiveness Analysis of Medical Technology (1980), by United States Congress Office of Technology Assessment
Filed under: Medical technology -- United States -- Cost effectiveness -- EvaluationFiled under: Medicine, Preventive -- Cost effectivenessFiled under: Neonatal intensive care -- Cost effectiveness- Neonatal Intensive Care for Low Birthweight Infants: Costs and Effectiveness (OTA-HCS-38; 1987), by United States Congress Office of Technology Assessment
Filed under: Nurse practitioners -- United States -- Cost effectivenessFiled under: Older people -- Hospital care -- Cost effectivenessFiled under: Older people -- Nursing home care -- Cost effectivenessFiled under: Psychotherapy -- United States -- Cost effectivenessFiled under: Respiratory therapy -- Washington (D.C.) -- Cost effectivenessFiled under: Students -- Drug use -- United States -- Prevention -- Cost effectivenessFiled under: Vaccination -- United States -- Cost effectivenessFiled under: Youth -- Drug use -- United States -- Prevention -- Cost effectivenessMore items available under broader and related terms at left. |